OR
ORIC Pharmaceuticals, Inc.
ORIC · NASDAQ
$12.67 -2.20% (-$0.29)
1M -5.87%
Market Cap $1.31B
P/E Ratio -
Div. Yield -
ROE 35.35%
Bulios Fair Price
$10.84
14.4% downside
Trenutna cena
$12.67
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica ORIC trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
1/9Valuation
59 /100
Fair P/B 3.44x
P/E N/A
EV/EBITDA N/A
Growth
100 /100
Growing Book val. growth 20.01%
EPS growth N/A
Rev. growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
Op. margin N/A
Quality
0 /100
Poor ROIC 40.32%
ROE 35.35%
ROA 34.68%
Debt
100 /100
Low Debt/Equity 0.01x
Current ratio 13.19x
Int. coverage N/A
Stability
76 /100
Stable Beta 0.99x
EPS volatility 6.52%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o ORIC
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Jacob Chacko
Employees
111
Headquarters
South San Francisco
Prihajajoči dogodki
12 NOV.
Earnings
Upcoming earnings report